EUVIMEDEUVIMED entdecken
Crossref

Enhanced Cytotoxicity of Half-Sandwich Ruthenium(II) Complex Containing Nitro -Substituted Salicyllimidazo[1,5- a ]pyridine toward Hormone-Independent Triple-Negative Breast Cancer Cells

Ibanpynhunlang Passi, Liji Muthirakalayil Abraham iD, Acily Skadon Worral Wilfred Raj, Manikandan Varadhan, Surya Muthuraman, Madhuri Priya Sivaramakrishnan, Prabha Vadivelu, Ravi Manoharan, Marappan Velusamy iD, Venugopal Rajendiran iD

Inorganic Chemistry · 2025

DOI: 10.1021/acs.inorgchem.5c00090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, 2025. Verfasst von Ibanpynhunlang Passi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, North Eastern Hill University, Shillong 793022, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ruthenium, Coordination Complexes, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben. Gefördert von: Indian Council of Medical Research, Department of Biotechnology, Ministry of Science and Technology, India, Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of organometallic ruthenium(II) arene complexes of the type [(η6-p-cymene)-Ru(L)Cl] (1-5), where L represents N,O-bidentate ligands such as 2-(1-phenylimidazo[1,5-α]pyridin-3-yl)-phenol (L1) and methyl (L2), methoxy (L3), fluoro (L4), and nitro (L5) substituted 2-(1-phenylimidazo[1,5-α]pyridin-3-yl)-phenol have been synthesized and characterized systematically. The geometry of complex 5 was confirmed through single-crystal XRD, revealing a typical pseudo-octahedral piano-stool configuration. The solution study demonstrates that Ru-Cl hydrolysis is feasible in an aqueous medium, and all the complexes exhibit a hydrolysis mechanism similar to that of cisplatin at both 4 mM and 100 mM NaCl concentrations. In DFT study, interestingly, the nitro-substituted ruthenium(II)-p-cymene complex (INO2, 5) shows slightly improved interaction with guanine. In vitro investigations have shown that ruthenium(II) complexes (1-5) exhibit growth-inhibitory effects against various cancer cell lines, including those of the breast (MDA-MB-231), lung (A549, NCI-H460), ovary (PA-1), and colon (HCT-116), compared to the uncoordinated ligand and metal precursor. These complexes have minimal impact on noncancerous lung cells (L132). Among them, complex 5 demonstrates the most potent antiproliferative activity, particularly in hormone-independent triple-negative breast cancer (TNBC) cells (MDA-MB-231; IC50 = 14.85 μM; SI = 36.74) and non-small cell lung cancer (NSCLC) cells (A549; IC50 = 23.76 μM; SI = 22.96), both of which are among the most common and clinically challenging cancer types to treat. Complex 5 induces cell cycle arrest at the G1 phase, promotes cell death, and reduces the metastatic potential of both breast and lung cancer cells. Notably, complex 5 exhibits greater efficacy in TNBC cells than NSCLC cells. Mechanistic studies reveal that complex 5 selectively inhibits the AKT1/mTOR signaling pathway in both breast and lung cancer cells, without affecting normal cells. Collectively, these findings suggest that complex 5 could be a promising candidate for the treatment of breast and lung cancers through inhibition of the AKT1/mTOR pathway. At the same time, the possibility that the cytotoxicity of these complexes is also mediated through DNA binding or other mechanisms cannot be excluded. Further investigations are warranted to elucidate the selectivity of these complexes toward specific cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsRutheniumCoordination ComplexesTriple Negative Breast NeoplasmsPyridinesHumansDrug Screening Assays, AntitumorCell ProliferationCell Line, TumorMolecular StructureDose-Response Relationship, DrugApoptosisStructure-Activity Relationship

Substanzen

Antineoplastic AgentsRutheniumCoordination ComplexesPyridines

Autor:innen und Institutionen

  • Department of Chemistry, North Eastern Hill University, Shillong 793022, India.
  • Department of Chemistry, School of Basic and Applied Sciences, Central University of Tamil Nadu, Thiruvarur 610101, India.
  • Department of Biochemistry, University of Madras, Guindy Campus, Chennai 600025, India.

ORCID-Profile: Liji Muthirakalayil Abraham, Marappan Velusamy, Venugopal Rajendiran

Förderung

  • Indian Council of Medical Research
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Passi, I., Abraham, L. M., Wilfred Raj, A. S. W., Varadhan, M., Muthuraman, S., Sivaramakrishnan, M. P., Vadivelu, P., Manoharan, R., Velusamy, M., & Rajendiran, V. (2025). Enhanced Cytotoxicity of Half-Sandwich Ruthenium(II) Complex Containing Nitro -Substituted Salicyllimidazo[1,5- a ]pyridine toward Hormone-Independent Triple-Negative Breast Cancer Cells. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.5c00090

Vancouver

Passi I, Abraham LM, Wilfred Raj ASW, Varadhan M, Muthuraman S, Sivaramakrishnan MP, et al. Enhanced Cytotoxicity of Half-Sandwich Ruthenium(II) Complex Containing Nitro -Substituted Salicyllimidazo[1,5- a ]pyridine toward Hormone-Independent Triple-Negative Breast Cancer Cells. Inorganic Chemistry. 2025. doi:10.1021/acs.inorgchem.5c00090

BibTeX
@article{Passi2025,
  author = {Passi, Ibanpynhunlang and Abraham, Liji Muthirakalayil and Wilfred Raj, Acily Skadon Worral and Varadhan, Manikandan and Muthuraman, Surya and Sivaramakrishnan, Madhuri Priya and Vadivelu, Prabha and Manoharan, Ravi and Velusamy, Marappan and Rajendiran, Venugopal},
  title = {Enhanced Cytotoxicity of Half-Sandwich Ruthenium(II) Complex Containing Nitro -Substituted Salicyllimidazo[1,5- a ]pyridine toward Hormone-Independent Triple-Negative Breast Cancer Cells},
  journal = {Inorganic Chemistry},
  year = {2025},
  doi = {10.1021/acs.inorgchem.5c00090}
}
Kostenlos starten →